231 related articles for article (PubMed ID: 17299493)
1. Effect of lycopene supplementation on insulin-like growth factor-1 and insulin-like growth factor binding protein-3: a double-blind, placebo-controlled trial.
Graydon R; Gilchrist SE; Young IS; Obermüller-Jevic U; Hasselwander O; Woodside JV
Eur J Clin Nutr; 2007 Oct; 61(10):1196-200. PubMed ID: 17299493
[TBL] [Abstract][Full Text] [Related]
2. Effects of lycopene on the insulin-like growth factor (IGF) system in premenopausal breast cancer survivors and women at high familial breast cancer risk.
Voskuil DW; Vrieling A; Korse CM; Beijnen JH; Bonfrer JM; van Doorn J; Kaas R; Oldenburg HS; Russell NS; Rutgers EJ; Verhoef S; van Leeuwen FE; van't Veer LJ; Rookus MA
Nutr Cancer; 2008; 60(3):342-53. PubMed ID: 18444168
[TBL] [Abstract][Full Text] [Related]
3. Effects of conjugated equine estrogen vs. raloxifene on serum insulin-like growth factor-i and insulin-like growth factor binding protein-3: a 2-year, double-blind, placebo-controlled study.
Duschek EJ; de Valk-de Roo GW; Gooren LJ; Netelenbos C
Fertil Steril; 2004 Aug; 82(2):384-90. PubMed ID: 15302288
[TBL] [Abstract][Full Text] [Related]
4. Effect of red clover-derived isoflavone supplementation on insulin-like growth factor, lipid and antioxidant status in healthy female volunteers: a pilot study.
Campbell MJ; Woodside JV; Honour JW; Morton MS; Leathem AJ
Eur J Clin Nutr; 2004 Jan; 58(1):173-9. PubMed ID: 14679383
[TBL] [Abstract][Full Text] [Related]
5. Lycopene supplementation inhibits lung squamous metaplasia and induces apoptosis via up-regulating insulin-like growth factor-binding protein 3 in cigarette smoke-exposed ferrets.
Liu C; Lian F; Smith DE; Russell RM; Wang XD
Cancer Res; 2003 Jun; 63(12):3138-44. PubMed ID: 12810641
[TBL] [Abstract][Full Text] [Related]
6. Short-term suppression of elevated growth hormone concentrations following insulin-like growth factor 1 administration in young adults with type 1 diabetes does not alter glomerular filtration or albumin excretion rates.
Williams RM; Yuen K; White D; Mallard B; Dalton RN; Acerini CL; Dunger DB
Clin Endocrinol (Oxf); 2006 Oct; 65(4):439-45. PubMed ID: 16984235
[TBL] [Abstract][Full Text] [Related]
7. Effects of the route of estrogen administration on insulinlike growth factor-I, IGF binding protein-3, and insulin resistance in healthy postmenopausal women: results from a randomized, controlled study.
Davis SR; Stuckey BG; Norman RJ; Papalia MA; Drillich A; Bell RJ
Menopause; 2008; 15(6):1065-9. PubMed ID: 18806686
[TBL] [Abstract][Full Text] [Related]
8. Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, and leptin in premenopausal women at high risk for developing breast cancer.
Eng-Wong J; Hursting SD; Venzon D; Perkins SN; Zujewski JA
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1468-73. PubMed ID: 14693739
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of growth hormone (GH) during extended treatment of adult Japanese patients with GH deficiency (GHD).
Chihara K; Kato Y; Kohno H; Takano K; Tanaka T; Teramoto A; Shimatsu A
Growth Horm IGF Res; 2008 Aug; 18(4):307-17. PubMed ID: 18282776
[TBL] [Abstract][Full Text] [Related]
10. The effects of a high-fruit and -vegetable, high-fiber, low-fat dietary intervention on serum concentrations of insulin, glucose, IGF-I and IGFBP-3.
Flood A; Mai V; Pfeiffer R; Kahle L; Remaley AT; Rosen CJ; Lanza E; Schatzkin A
Eur J Clin Nutr; 2008 Feb; 62(2):186-96. PubMed ID: 17487212
[TBL] [Abstract][Full Text] [Related]
11. No effect of red clover-derived isoflavone intervention on the insulin-like growth factor system in women at increased risk of colorectal cancer.
Vrieling A; Rookus MA; Kampman E; Bonfrer JM; Bosma A; Cats A; van Doorn J; Korse CM; Witteman BJ; van Leeuwen FE; van't Veer LJ; Voskuil DW
Cancer Epidemiol Biomarkers Prev; 2008 Oct; 17(10):2585-93. PubMed ID: 18842999
[TBL] [Abstract][Full Text] [Related]
12. The changes of IGF binding proteins after rhGH administration to patients totally dependent on parenteral nutrition.
Justová V; Lacinová Z; Melenovský V; Marek J; Holly JM; Hass T
Growth Horm IGF Res; 2001 Dec; 11(6):407-15. PubMed ID: 11914029
[TBL] [Abstract][Full Text] [Related]
13. Phase II randomized clinical trial of lycopene supplementation before radical prostatectomy.
Kucuk O; Sarkar FH; Sakr W; Djuric Z; Pollak MN; Khachik F; Li YW; Banerjee M; Grignon D; Bertram JS; Crissman JD; Pontes EJ; Wood DP
Cancer Epidemiol Biomarkers Prev; 2001 Aug; 10(8):861-8. PubMed ID: 11489752
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys.
Hoppe C; Mølgaard C; Dalum C; Vaag A; Michaelsen KF
Eur J Clin Nutr; 2009 Sep; 63(9):1076-83. PubMed ID: 19471293
[TBL] [Abstract][Full Text] [Related]
15. The effect of submaximal exercise on immuno- and bioassayable IGF-I activity in patients with GH-deficiency and healthy subjects.
Kanaley JA; Frystyk J; Møller N; Dall R; Chen JW; Nielsen SC; Christiansen JS; Jørgensen JO; Flyvbjerg A
Growth Horm IGF Res; 2005 Aug; 15(4):283-90. PubMed ID: 16027018
[TBL] [Abstract][Full Text] [Related]
16. Interactions between insulin, body fat, and insulin-like growth factor axis proteins.
Ahmed RL; Thomas W; Schmitz KH
Cancer Epidemiol Biomarkers Prev; 2007 Mar; 16(3):593-7. PubMed ID: 17372257
[TBL] [Abstract][Full Text] [Related]
17. Multidimensional reference regions for IGF-I, IGFBP-2 and IGFBP-3 concentrations in serum of healthy adults.
Mattsson A; Svensson D; Schuett B; Osterziel KJ; Ranke MB
Growth Horm IGF Res; 2008 Dec; 18(6):506-16. PubMed ID: 18550406
[TBL] [Abstract][Full Text] [Related]
18. Serum levels of insulin-like growth factor-I and insulin-like growth factor-I binding protein-3: quality control for studies of stored serum.
Berrigan D; Potischman N; Dodd KW; Nicar M; McQuillan G; Lavigne JA; Barrett JC; Ballard-Barbash R
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):1017-22. PubMed ID: 17507631
[TBL] [Abstract][Full Text] [Related]
19. Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30-50-year-old women.
Schmitz KH; Ahmed RL; Yee D
Cancer Epidemiol Biomarkers Prev; 2002 Dec; 11(12):1597-604. PubMed ID: 12496050
[TBL] [Abstract][Full Text] [Related]
20. Increased serum concentration of IGFBP-4 and IGFBP-5 in healthy adults during one month's treatment with supraphysiological doses of growth hormone.
Ehrnborg C; Ohlsson C; Mohan S; Bengtsson BA; Rosén T
Growth Horm IGF Res; 2007 Jun; 17(3):234-41. PubMed ID: 17347011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
